PenderFund Capital Management »

Xenon Pharmaceuticals shares owned by PenderFund Capital Management

Quarter-by-quarter ownership of Xenon Pharmaceuticals (XENE) shares owned by PenderFund Capital Management from 13F filings

Historical chart of PenderFund Capital Management investment in Xenon Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Xenon Pharmaceuticals held by PenderFund Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xenon Pharmaceuticals by PenderFund Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $275k 6.9k 40.15

More positions owned by PenderFund Capital Management

First Majestic Silver Corp Note 0.375% 1/1 (Principal)
Abrdn Platinum Etf Trust Physcl Platm Shs (PPLT)
Equinox Gold Corp equities (EQX)
Duke Energy Corp Note 4.125% 4/1 (Principal)
Ssr Mining In Note 2.500% 4/0 (Principal)
Equinox Gold Corp Note 4.750%10/1 (Principal)
Southern Note 4.500% 6/1 (Principal)
Pdd Holdings Note 12/0 (Principal)
Esperion Therapeutics (ESPR)
Beyond Meat Note 3/1 (Principal)
Nio Note 3.875%10/1 (Principal)
Wolfspeed Note 1.750% 5/0 (Principal)
PAR Technology Corporation (PAR)
Cardlytics Note 4.250% 4/0 (Principal)
Wolfspeed Note 1.875%12/0 (Principal)

View all positions for PenderFund Capital Management

Top funds holding Xenon Pharmaceuticals

FMR
venBio Select Advisor
BlackRock
Driehaus Capital Management
Henderson Group
Wellington Management Company
Braidwell
Capital Research and Management Company - Division 3
Commodore Capital
Polar Capital Holdings
Holocene Advisors
Alliancebernstein
State Street Corporation
Millennium Management
Affinity Asset Advisors

View all funds holding Xenon Pharmaceuticals